Literature DB >> 33466755

The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies.

Muhammad Imran Sohail1, Yaprak Dönmez-Cakil2, Dániel Szöllősi3, Thomas Stockner3, Peter Chiba4.   

Abstract

The bile salt export pump (BSEP/ABCB11) is responsible for the transport of bile salts from hepatocytes into bile canaliculi. Malfunction of this transporter results in progressive familial intrahepatic cholestasis type 2 (PFIC2), benign recurrent intrahepatic cholestasis type 2 (BRIC2) and intrahepatic cholestasis of pregnancy (ICP). Over the past few years, several small molecular weight compounds have been identified, which hold the potential to treat these genetic diseases (chaperones and potentiators). As the treatment response is mutation-specific, genetic analysis of the patients and their families is required. Furthermore, some of the mutations are refractory to therapy, with the only remaining treatment option being liver transplantation. In this review, we will focus on the molecular structure of ABCB11, reported mutations involved in cholestasis and current treatment options for inherited BSEP deficiencies.

Entities:  

Keywords:  ABCB11; BRIC; BSEP; PFIC2; bile salts; chaperones; intrahepatic cholestasis

Mesh:

Substances:

Year:  2021        PMID: 33466755      PMCID: PMC7830293          DOI: 10.3390/ijms22020784

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  138 in total

1.  Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.

Authors:  Tarek Moustafa; Peter Fickert; Christoph Magnes; Christian Guelly; Andrea Thueringer; Sasa Frank; Dagmar Kratky; Wolfgang Sattler; Helga Reicher; Frank Sinner; Judith Gumhold; Dagmar Silbert; Günter Fauler; Gerald Höfler; Achim Lass; Rudolf Zechner; Michael Trauner
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

2.  Interaction of bile salts with rat canalicular membrane vesicles: evidence for bile salt resistant microdomains.

Authors:  Christelle Guyot; Bruno Stieger
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

3.  Short- and medium-chain fatty acids enhance the cell surface expression and transport capacity of the bile salt export pump (BSEP/ABCB11).

Authors:  Takuya Kato; Hisamitsu Hayashi; Yuichi Sugiyama
Journal:  Biochim Biophys Acta       Date:  2010-04-14

4.  Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells.

Authors:  Suneet Shukla; Candice Schwartz; Khyati Kapoor; Abdul Kouanda; Suresh V Ambudkar
Journal:  Drug Metab Dispos       Date:  2011-10-31       Impact factor: 3.922

Review 5.  Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.

Authors:  Bruno Stieger; Zainab M Mahdi
Journal:  J Pharm Sci       Date:  2017-04-03       Impact factor: 3.534

6.  Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.

Authors:  Emmanuel Gonzales; Brigitte Grosse; Brice Schuller; Anne Davit-Spraul; Filomena Conti; Catherine Guettier; Doris Cassio; Emmanuel Jacquemin
Journal:  Hepatology       Date:  2015-04-08       Impact factor: 17.425

7.  Liver transcript analysis reveals aberrant splicing due to silent and intronic variations in the ABCB11 gene.

Authors:  Anne Davit-Spraul; Christophe Oliveira; Emmanuel Gonzales; Pauline Gaignard; Patrice Thérond; Emmanuel Jacquemin
Journal:  Mol Genet Metab       Date:  2014-07-15       Impact factor: 4.797

8.  Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.

Authors:  Tatehiro Kagawa; Norihito Watanabe; Kaori Mochizuki; Asano Numari; Yoshie Ikeno; Johbu Itoh; Hirotoshi Tanaka; Irwin M Arias; Tetsuya Mine
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-18       Impact factor: 4.052

9.  Human ABCB1 with an ABCB11-like degenerate nucleotide binding site maintains transport activity by avoiding nucleotide occlusion.

Authors:  Katalin Goda; Yaprak Dönmez-Cakil; Szabolcs Tarapcsák; Gábor Szalóki; Dániel Szöllősi; Zahida Parveen; Dóra Türk; Gergely Szakács; Peter Chiba; Thomas Stockner
Journal:  PLoS Genet       Date:  2020-10-08       Impact factor: 5.917

10.  Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center.

Authors:  Isabella Giovannoni; Francesco Callea; Emanuele Bellacchio; Giuliano Torre; Jean De Ville De Goyet; Paola Francalanci
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

View more
  4 in total

Review 1.  Role and Regulation of Hepatobiliary ATP-Binding Cassette Transporters during Chemical-Induced Liver Injury.

Authors:  Carolina I Ghanem; Jose E Manautou
Journal:  Drug Metab Dispos       Date:  2022-08-01       Impact factor: 3.579

2.  ABC Transporters in Human Diseases: Future Directions and Therapeutic Perspectives.

Authors:  Thomas Falguières
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

Review 3.  Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies.

Authors:  Seema Alam; Bikrant Bihari Lal
Journal:  World J Hepatol       Date:  2022-01-27

Review 4.  Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review).

Authors:  Wenyu Luo; Shiqi Guo; Yang Zhou; Junfeng Zhu; Jingwen Zhao; Mengyao Wang; Lixuan Sang; Bingyuan Wang; Bing Chang
Journal:  Int J Oncol       Date:  2022-08-05       Impact factor: 5.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.